Работы, на которые ссылается эта работа

Работ: 292

Работа: Nanoparticle-Based PCSK9 Inhibition in Viral Infections: Evaluating Clinical Limitations and Advancing Therapeutic Strategies

Polymeric Nanoparticles for Drug Delivery
Maximilian A. Beach, Umeka Nayanathara, Yanting Gao +4
Обзорная статья2024Цитирований: 7
ABI
The Evolving Future of PCSK9 Inhibitors
Robert S. Rosenson, Robert A. Hegele, Sergio Fazio +1
Обзорная статья2018Цитирований: 4
ABI
Spotlight on therapeutic efficiency of green synthesis metals and their oxide nanoparticles in periodontitis
Mohammad Kiarashi, Parham Mahamed, Nader Ghotbi +6
Статья2024Цитирований: 3
ABI
HIV Infection and the Risk of Acute Myocardial Infarction
Matthew S. Freiberg, Chung-Chou H. Chang, Lewis H. Kuller +25
Статья2013Цитирований: 3
ABI
Current hurdles to the translation of nanomedicines from bench to the clinic
Snežana Đorđević, María Medel Gonzalez, Inmaculada Conejos‐Sánchez +6
Обзорная статья2021Цитирований: 3
ABI
Recent advances in metal nanoparticles to treat periodontitis
Kamyar Nasiri, Seyed Mohammad Reza Masoumi, Sara Amini +7
Обзорная статья2023Цитирований: 3
ABI
The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases
Elham Oveili, Somayeh Vafaei, Haniyeh Bazavar +4
Обзорная статья2023Цитирований: 3
ABI
Mesenchymal Stem Cell-based Scaffolds in Regenerative Medicine of Dental Diseases
Mohammad Kiarashi, Hannaneh Bayat, Seyed Abbas Shahrtash +6
Обзорная статья2024Цитирований: 3
ABI
A Common PCSK9Haplotype, Encompassing the E670G Coding Single Nucleotide Polymorphism, Is a Novel Genetic Marker for Plasma Low-Density Lipoprotein Cholesterol Levels and Severity of Coronary Atherosclerosis
Suet N. Chen, Christie M. Ballantyne, Antonio M. Gotto +3
Статья2005Цитирований: 3
ABI
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh +10
Обзорная статья2022Цитирований: 3
ABI
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
Kevin Fitzgerald, Maria Frank-Kamenetsky, Svetlana Shulga‐Morskaya +17
Статья2013Цитирований: 2
ABI
Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics
Nicolas Bertrand, P. Grenier, Morteza Mahmoudi +7
Статья2017Цитирований: 2
ABI
New Approaches for Targeting PCSK9: Small-Interfering Ribonucleic Acid and Genome Editing
Reindert F. Oostveen, Amit V. Khera, Sekar Kathiresan +5
Обзорная статья2023Цитирований: 2
ABI
Lipid-based nanoparticle formulations for small molecules and RNA drugs
Ludger M. Ickenstein, Patrick Garidel
Обзорная статья2019Цитирований: 2
ABI
Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)
Rainer Schulz, Klaus‐Dieter Schlüter, Ulrich Laufs
Обзорная статья2015Цитирований: 2
ABI
PCSK9 and LDLR degradation
Thomas A. Lagace
Обзорная статья2014Цитирований: 2
ABI
PCSK9 induces a pro-inflammatory response in macrophages
Chiara Ricci, Massimiliano Ruscica, Marina Camera +10
Статья2018Цитирований: 2
ABI
PCSK9 and inflammation: a review of experimental and clinical evidence
Amir Abbas Momtazi‐Borojeni, Sarvenaz Sabouri-Rad, Antonio M. Gotto +5
Обзорная статья2019Цитирований: 2
ABI
Proprotein Convertase Subtilisin/Kexin Type 9
Chiara Macchi, Nicola Ferri, Cesare R. Sirtori +3
Обзорная статья2021Цитирований: 2
ABI
PCSK9-targeted therapies: present and future approaches
Mahmoud Al Rifai, Christie M. Ballantyne
Обзорная статья2021Цитирований: 2
ABI
May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
Roberto Scicali, Antonino Di Pino, Salvatore Piro +2
Обзорная статья2020Цитирований: 2
ABI
Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
Fotios Barkas, Haralampos Milionis, Georgia Anastasiou +1
Обзорная статья2020Цитирований: 2
ABI
PCSK9
Nabil G. Seidah, Zuhier Awan, Michel Chrétien +1
Обзорная статья2014Цитирований: 2
ABI
Adverse Events Associated With <scp>PCSK</scp>9 Inhibitors: A Real‐World Experience
Muhammed T. Gürgöze, A H G Muller-Hansma, Michelle M. Schreuder +3
Статья2018Цитирований: 2
ABI
A multi-target therapeutic potential of Prunus domestica gum stabilized nanoparticles exhibited prospective anticancer, antibacterial, urease-inhibition, anti-inflammatory and analgesic properties.
Nazar Ul Islam, Raza Amin, Muhammad Shahid +3
Статья2017Цитирований: 2
ABI